Discovery of Aspartame

You can trace aspartame’s discovery to a 1965 lab accident: chemist James M. Schlatter was making a gastrin-related compound when powder from a flask got on his finger, and tasting it revealed an intense sweetness. The molecule turned out to be a methyl ester dipeptide from aspartic acid and phenylalanine, about 180–200 times sweeter than sugar. That surprise led to patents, years of safety debate, and eventual approval in more than 90 countries—there’s more to uncover ahead.

Key Takeaways

• Aspartame was discovered accidentally in 1965 by chemist James M. Schlatter while he was developing an anti-ulcer gastrin-blocking drug.
• Schlatter noticed its sweetness after powder from a recrystallized flask got on his finger and he licked it.
• The sweet compound was a methyl ester dipeptide made from aspartic acid and phenylalanine.
• Its precise molecular structure makes it about 180–200 times sweeter than ordinary table sugar.
• After the accidental discovery, Schlatter patented aspartame, leading to later commercialization as Equal and NutraSweet.

How Aspartame Was Discovered by Accident

Although researchers at G.D. Searle in Skokie were chasing an anti-ulcer drug in 1965, you can trace aspartame's origin to pure 1965 serendipity. Lead chemist James M. Schlatter was building a gastrin-blocking compound and synthesized aspartame as an intermediate. He combined aspartic acid and phenylalanine, made the methyl ester dipeptide, and recrystallized it from ethanol. During handling, powder leaked onto a flask and contaminated his finger.

When Schlatter later licked his finger to grab a piece of paper, you see a clear break from lab safety. He immediately noticed an intense sweet taste and tracked it to the recrystallized compound on his skin. That accidental taste test redirected the project, turning a failed drug pathway into the starting point for aspartame's development as a commercial sweetener. Aspartame is about 180–200 times sweeter than sucrose. Because aspartame breaks down when exposed to heat, it is rarely used in baked goods formulations and remains far more common in soft drinks and yogurt. On this path, the company moved quickly enough that a patent application for the sweetener was filed and granted in 1970.

Why Aspartame Is So Sweet

What makes aspartame stand out is its precise molecular design. You’re tasting a dipeptide built from aspartic acid and phenylalanine, two amino acids your body already knows. A small methyl addition on phenylalanine changes how the molecule fits sweet receptors, and that molecular binding drives intense sweetness. Because its atoms sit in just the right arrangement, your sensory perception reads a powerful sugar-like signal. It was first developed in 1965, a history milestone that helped launch decades of research and widespread use.

You get about 200 times the sweetness of table sugar from a tiny amount, so manufacturers use far less by weight. Even though aspartame has 4 calories per gram, those minuscule servings contribute almost no practical calories. It also doesn’t raise glucose levels, which helps explain its popularity in diet sodas, gum, yogurt, protein bars, and many sugar-free products worldwide today. FDA considers aspartame safe under approved conditions of use and sets an ADI of 50 mg/kg body weight per day.

How Aspartame Reached Patent and Early Development

Aspartame’s path to patent began with a lab accident in December 1965, when chemist James Schlatter at G.D. Searle accidentally tasted a compound while synthesizing a gastrin-related tetrapeptide. You can trace the patent timeline from that moment: Schlatter filed after recognizing the intense sweetness of the aspartic acid and phenylalanine methyl ester, and U.S. Patent 3,492,131 was granted on January 27, 1970. Because Schlatter worked for Searle, the company controlled the invention and its manufacturing future. Aspartame was later marketed under Equal and NutraSweet.

You then see early development move from discovery to validation. Searle reproduced the result, tested the sweetener thoroughly, and referenced it in 1969 scientific literature. In 1973, the company filed its food additive petition. Later, production innovations explored microbial methods for larger-scale Asp-Phe-OMe synthesis. Aspartame later received FDA approval for use in dry goods in 1981.

Why Aspartame Approval Faced Safety Controversy

Because the sweetener emerged from a 1965 lab discovery and moved quickly toward commercialization, its approval soon drew unusually intense scrutiny. You can trace the regulatory controversy to early warnings from critics like John Olney and James Turner, who questioned possible brain lesions, tumors, neurotoxic effects, and risks for people with phenylketonuria.

When Searle sought FDA approval in 1973, concerns about data integrity in animal studies slowed the process. Although the FDA approved aspartame in 1974, objections arrived immediately, citing rat tumor findings and a flawed monkey pilot study involving phenylalanine. Later assessments by international health bodies drew a distinction between hazard and risk, with IARC classifying aspartame as possibly carcinogenic to humans while JECFA maintained that intake within the acceptable daily limit remains safe. The FDA has also continued to state that aspartame is safe under approved conditions of use, reflecting its risk assessment role.

An FDA task force then found some research questionable, prompting a stay of approval and deeper investigation. In 1980, a Public Board of Inquiry revoked the earlier approval, saying more evidence was needed to rule out any brain-tumor link conclusively.

How Aspartame Won Global Approval and Adoption

Although early objections delayed its path, aspartame gained broad approval after regulators revisited the evidence, corrected disputed conclusions, and set clear safety limits for daily intake.

You can trace that shift through key regulatory milestones: the FDA’s 1981 reapproval for dry foods, JECFA’s 40 mg/kg acceptable daily intake, and the GAO’s 1987 finding that proper procedures were followed. A later EFSA review published 600 datasets and concluded that aspartame and its metabolites posed no toxicity concern at current exposure levels.

You then see international endorsements accelerate adoption. Canada accepted FDA data in 1981, Australia followed in 1986, and the European Union approved aspartame in 1994.

More than 90 countries eventually judged it safe at reasonable consumption levels.

Later, EFSA’s 2009–2013 review of 600 datasets found no toxicity concerns and confirmed that typical exposure stayed below the accepted daily limit, reinforcing continued global use and confidence. In 2023, however, IARC classified aspartame as possibly carcinogenic, renewing public debate even as other bodies maintained existing intake guidance.